Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency

Journal of Clinical Investigation

Volumn 99, Issue 7, 1997, Pages 1699-1703

  Ammann, Patrick ^a,c   Rizzoli, René ^a   Bonjour, Jean Philippe ^a   Bourrin, Sandrine ^a   Meyer, Jean Marc ^b   Vassalli, Pierre ^b   Garcia, Irène ^b  

^a Univ M   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c University Hospitals   (Switzerland)

Author keywords

biomechanics; DXA; osteocalcin; osteoporosis; pathophysiology

Indexed keywords

OSTEOCALCIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE REMODELING; BONE STRENGTH; BONE TURNOVER; CONTROLLED STUDY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; MOUSE; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0030950131     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119333     Document Type: Article

References (35)

1. Bertolini, D.R., G.E. Nedwin, T.S. Bringman, D.D. Smith, and G.R. Mundy. 1986. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature (Lond.). 319:516-518.
2. Chaudhary, L.R., T.C. Spelsberg, and B.L.P. Riggs. 1992. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and tumor necrosis factor-α: lack of regulation by 17β-estradiol. Endocrinology. 130:2528-2534.
3. Johnson, R.A., B.F. Boyce, G.R. Mundy, and G.D. Roodman. 1989. Tumors producing human tumor necrosis factor induce hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology. 124:1424-1427.
4. Parfitt, A.M. 1994. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J. Cell. Biochem. 55:273-286.
5. Riggs, B.L. and L.J. Melton III. 1986. Involutional osteoporosis. N. Engl. J. Med. 314:1676.
6. Kalu, D.N. 1991. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15:175-191.
7. Miller, S.C., and T.J. Wronski. 1992. Long-term osteopenic changes in cancellous bone structure in ovariectomized rats. Anat. Rec. 236:433-441.
8. Peck, W.A., P. Burckhardt, C. Christiansen, H.A. Fleisch, H.K. Genant, C. Gennari, T.J. Martin, L. Martini, R. Morita, E. Ogata, A. Rapado, I. Shulman, P.H. Stern, and R.T.T. Young. 1993. Consensus development conference - Diagnosis, prophylaxis, and treatment of osteoporosis - rapid publication. Am. J. Med. 94:646-650.
9. Black, K., I.R. Garrett, and G.R. Mundy. 1991. Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology. 128:2657-2659.
10. Jilka, R.L., G. Hangoc, G. Girasole, G. Passeri, D.C. Williams, J.S. Abrams, B. Boyce, H. Broxmeyer, and S.C. Manolagas. 1992. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science (Wash. DC). 257:88-91.
11. Girasole, G., R.L. Jilka, G. Passeri, S. Boswell, G. Boder, D.C. Williams, and S.C. Manolagas. 1992. 17β estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 89:883-891.
12. Horowitz, M.C. 1993. Cytokines and estrogen in bone: anti-osteoporotic effects. Science (Wash. DC). 260:626-627.
13. Manolagas, S.C., and R.L. Jilka. 1995. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 332:305-311.
14. Mundy, G.R. 1992. Effects of TNF on bone and cartilage. In Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. B. Beutler, editor. Raven Press, Ltd. New York. 107-116.
15. Pacifici, R., L. Rifas, R. McCracken, I. Vered, C. McMurtry, L.V. Avioli, and W.A. Peck. 1989. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc. Natl. Acad. Sci. USA. 86:2398-2402.
16. Pacifici, R., C. Brown, E. Puscheck, E. Friedrich, E. Slatopolsky, D. Maggio, R. McCracken, and L. Avioli. 1991. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. USA. 88:5134-5138.
17. Pacifici, R., J.L. Vannice, L. Rifas, and R.B. Kimble. 1993. Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy. J. Clin. Endocrinol. Metab. 77:1135-1141.
18. Kimble, R.B., J.L. Vannice, D.C. Bloedow, R.C. Thompson, W. Hopfer, V.T. Kung, C. Brownfield and R. Pacifici. 1994. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J. Clin. Invest. 93:1959-1967.
19. Garcia, I., Y. Miyazaki, K. Araki, R. Lucas, G.E. Grau, G. Milon, Y. Belkaid, C. Montixi, W. Lesslauer, and P. Vassalli. 1995. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunology 25:2401-2407.
20. Ammann, P., R. Rizzoli, D. Slosman, and J.P. Bonjour. 1992. Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy X-ray absorptiometry. J. Bone Miner. Res. 7:311-316.
21. Ammann, P., R. Rizzoli, J.-M. Meyer, and J.-P. Bonjour. 1996. Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats. Osteoporosis Inf. 6:219-227.
22. Bourrin, S., S. Palle, R. Pupier, L. Vico, and C. Alexandre. 1995. Effects of physical training on bone adaptation in three zones of the rat tibia. J. Bone Miner. Res. 10: 1745-1752.
23. Parfitt, A.M. 1987. Bone histomorphometry: standardization of nomenclature, symbols and units. J. Bone Miner. Res. 2:595-610.
24. Parfitt, A.M. 1983. Stereologic basis of bone histomorphometry: theory of quantitative microscopy and reconstruction of the third dimension. In Bone Histomorphometry: Techniques and Interpretation. R.R. Recker, editor. CRC Press. Boca Raton. FL. 53-89.
25. Chen, P.S., T.Y. Toribara, and H. Warner. 1956. Microdetermination of phosphorus. Anal. Chem. 28:1756.
26. Gentile, M., R. Balena, H. Chen, and G.A. Rodan. 1995. Interleukin-1 beta gene deletion ("knock-out") does not reduce bone loss in ovariectomized mice. J. Bone Miner. Res. 10:s364.
27. Kitazawa, R., R.B. Kimble, J.L. Vannice, V.T. Kung, and R. Pacifici. 1994. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J. Clin. Invest. 94:2397-2406.
28. Kimble, R.B., A.B. Matayoshi, J.L. Vannice, V.T. Kung, C. Williams, and R. Pacifici. 1995. Simulatneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology. 136:3054-3061.
29. Felix, R., M.G. Cecchini, and H. Fleisch. 1990. Macrophage colony stimulating factor restores in vivo bone resorption in the OP/OP osteopetrotic mouse. Endocrinology. 127:2592-2594.
30. Poli, V., R. Balena, E. Fattori, A. Markatos, M. Yamamoto, H. Tanaka, G. Ciliberto, G.A. Rodan, and F. Costantini. 1994. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO (Eur. Mol. Biol. Organ.) J. 13:1189-1196.
31. Kimble. R.B., S.D. Bain, V. Kung, and R. Pacifici. 1995. Inhibition of IL-6 activity in genetically normal mice does not prevent ovariectomy-induced bone loss. J. Bone Miner. Res. 10:S160.
32. Udagawa, N., N. Takahashi, T. Katagiri, T. Tamura, S. Wada, D.M. Findlay, T.J. Martin, H. Hirota, T. Tada, T. Kishimoto, and T. Suda. 1995. Interleukin (IL-6) induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J. Exp. Med. 182:1461-1468.
33. Felix, R., M.G. Cecchini, W. Hofstetter, H.L. Guenther, and H. Fleisch. 1991. Production of granulocyte-macrophage (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) by rat clonal osteoblastic cell line IRC 10/30-mycl stimulated by tumor necrosis factor-alpha. Endocrinology. 128:661-667.
34. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10.411-452.
35. Yamada, H., S. Iwase, M. Mohri, and D. Kufe. 1991. Involement of a nuclear factor-kappa B-like protein in induction of the macrophage colony-stimulating factor gene by tumor necrosis factor. Blood. 78 (8):1988-1995.